Form 8-K · Current report
American Express 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0000004962
- Accession no.
- 0000004962-26-000327
Summary
American Express announced a proposed public offering of depositary shares, each representing a 1/1,000th interest in a new series of Fixed Rate Reset Noncumulative Preferred Shares, Series E, and said it intends to use the net proceeds for general corporate purposes, including to partially or fully redeem its outstanding 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D. Pricing of the offering, and therefore whether any Series D redemption occurs and in what amount or timing, is subject to market conditions, with no assurance the offering will price or close.
Key points
- The offering is described in a preliminary prospectus supplement dated August 5, 2026 filed with the SEC.
- The Series E preferred shares carry a $1.662/3 par value per share.
- The filing states it is not an offer to sell or a solicitation of an offer to buy the shares, nor a notice of redemption for the Series D shares.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01 Other Events. On August 5, 2026, American Express Company (the “Company”) announced the launch of a proposed public offering (the “Offering”) of depositary shares (the “Depositary Shares”), each representing a 1/1,000th interest in a share of a new series of Fixed Rate Reset Noncumulative Preferred Shares, Series E, $1.662/3 par value per share (the “Preferred Shares”). The Company intends to use the net proceeds from the Offering for general corporate purposes, including to partially or fully redeem the outstanding shares of its 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, $1.662/3 par value per share (the “Series D Preferred Shares”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.